Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Daniel Andres Real"'
Autor:
Ignacia Paz Torres Fredes, Elizabeth Nicole Cortés-Adasme, Bruno Andrés Barrientos, Juan Pablo Real, Cesar Gerardo Gomez, Santiago Daniel Palma, Marcelo Javier Kogan, Daniel Andrés Real
Publikováno v:
Pharmaceuticals, Vol 17, Iss 11, p 1453 (2024)
Background: Gold nanoparticles can generate heat upon exposure to radiation due to their plasmonic properties, which depend on particle size and shape. This enables precise control over the release of active substances from polymeric pharmaceutical f
Externí odkaz:
https://doaj.org/article/fce52efa86ee4108955257d226dea493
Triclabendazole belongs to the class II/IV of the Biopharmaceuticals Classification System, and its low aqueous solubility represents a major drawback during the development of effective dosage forms. Therefore, the goal of this study was to elucidat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6993b106bbb59aded95f158b9f9c7385
https://link.springer.com/athens-shibboleth-login?previousUrl=https://link.springer.com/article/10.1208/s12249-019-1551-4
https://link.springer.com/athens-shibboleth-login?previousUrl=https://link.springer.com/article/10.1208/s12249-019-1551-4
Autor:
Stefan Hoffmann, Claudio J. Salomon, Darío Leonardi, Daniel Andres Real, Francisco M. Goycoolea
Publikováno v:
Journal of Molecular Liquids. 321:114743
Lately, nanoemulsions loaded with hydrophobic drugs have been successfully developed to improve the treatment of several global diseases. On this subject, a detailed study of the crucial role of the excipients and the experimental conditions used for
Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations
Autor:
Francisco M. Goycoolea, Daniel Andres Real, Claudio J. Salomon, Stefan Hoffmann, Darío Leonardi
Publikováno v:
PLoS One
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0207625 (2018)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0207625 (2018)
Triclabendazole is a poorly-water soluble (0.24 μg/mL) compound classified into the Class II/IV of the Biopharmaceutical Classification System. It is the drug of choice to treat fascioliasis, a neglected parasitic disease worldwide disseminated. Tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83cd523b1752a1afc0012ddba796451a
https://eprints.whiterose.ac.uk/140008/1/journal.pone.0207625.pdf
https://eprints.whiterose.ac.uk/140008/1/journal.pone.0207625.pdf
Autor:
O. E. Osella, Julian Horacio de la Torre, Karina Pellicer, María Pía Silvestrini, Daniel Andres Real, Julio Alberto Copes, Victoria Brusa, C.A. Bainotti
Publikováno v:
Analecta Veterinaria, Vol 38, Iss 1 (2018)
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
SEDICI (UNLP)
Universidad Nacional de La Plata
instacron:UNLP
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
El objetivo general del trabajo fue evaluar el efecto del consumo de agua electroactivada (AE) en bovinos de engorde a corral (feedlot); los objetivos particulares fueron: 1. determinar la presencia de E. coli O157 y de Salmonella spp. en materia fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f39073ce1b9af173df963561e5bca0
http://sedici.unlp.edu.ar/handle/10915/67744
http://sedici.unlp.edu.ar/handle/10915/67744
Publikováno v:
AAPS PharmSciTech. 19(5)
Triclabendazole is the first-line drug of choice to treat and control fasciolasis, a neglected parasitic human disease. It is a class II/IV compound according to the Biopharmaceutics Classification System. Thus, the aim of this study was to improve a
Autor:
Darío Leonardi, Claudio J. Salomon, Victoria Lucia Alonso, Ariel Mariano Silber, Higo Fernando Santos Souza, Esteban Serra, Sandra Carla Rocha, Daniel Andres Real
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Objectives: To develop an alcohol-free solution suitable for children of benznidazole, the drug of choice for treatment of Chagas disease. Methods: In a quality-by-design approach, a systematic optimisation procedure was carried out to estimate the v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5836a78ab3502d4931e9fe30eabb5a5
Wiley Online Library
Wiley Online Library
Autor:
Claudio J. Salomon, Marina del Valle Soazo, Daniel Andres Real, A. Frattini, Alicia G. Luque, Marisa S. Biasoli, Maria V. Martinez, Darío Leonardi, Alejandro Cesar Olivieri
The objective of the present paper was the development and the full characterization of antifungal films. Econazole nitrate (ECN) was loaded in a polymeric matrix formed by chitosan (CH) and carbopol 971NF (CB). Polyethylene glycol 400 and sorbitol w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6731320af70cb05d6a6e25f174a8df
http://link.springer.com/article/10.1208/s12249-012-9894-0
http://link.springer.com/article/10.1208/s12249-012-9894-0
Autor:
Juan Pablo Real, Daniel Andrés Real, Lucía Lopez-Vidal, Bruno Andrés Barrientos, Karen Bolaños, Mariano Guillermo Tinti, Nicolás Javier Litterio, Marcelo Javier Kogan, Santiago Daniel Palma
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1387 (2023)
Niclosamide (NICLO) is a recognized antiparasitic drug being repositioned for Helicobacter pylori. The present work aimed to formulate NICLO nanocrystals (NICLO-NCRs) to produce a higher dissolution rate of the active ingredient and to incorporate th
Externí odkaz:
https://doaj.org/article/5f1408cf27ce4b19980d6818d5604ee2
Autor:
Érica Tex Paulino, Monique Ribeiro de Lima, Alessandra Lifsitch Viçosa, Cleber Hooper da Silva, Claudio Javier Salomon, Daniel Andrés Real, Dario Leonardi, Clélia Christina Mello Silva, Antonio Henrique Almeida de Moraes Neto
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Schistosomiasis is a widely distributed parasitic disease and one of the most important neglected tropical diseases globally, for which Praziquantel® (PZQ) is the only available treatment. In this context, tests with new PZQ formulations become rele
Externí odkaz:
https://doaj.org/article/cc0f04eb3a1a4e8389b24cccc2aea90e